Acinetobacter is a complex genus, and historically, there has been confusion about the
existence of multiple species. The species commonly cause nosocomial infections …

Managing Acinetobacter baumannii infections : Current Opinion in Infectious Diseases
Managing Acinetobacter baumannii infections : Current Opinion in Infectious Diseases Log in or …

To give an update on the molecular epidemiology and global distribution of carbapenemase
encoding genes, we subjected 313 carbapenem-resistant Acinetobacter baumannii isolated …

Background Device-associated health care-associated infections (DA-HAIs) in intensive
care unit (ICU) patients constitute a major therapeutic issue complicating the regular …

Due to the emergence of antimicrobial resistance, new alternative therapies are needed.
Silver was used to treat bacterial infections since antiquity due to its known antimicrobial …

This study aimed to describe severe infections with extensively drug-resistant Acinetobacter
baumannii–calcoaceticus complex (XDR-ABC), as well as to investigate risk factors for …

Objectives: The objectives of this study were to detect those characteristics that were
specifically associated with infection or colonization by Acinetobacter baumannii, describe …

Background Acinetobacter baumannii can cause serious healthcare-associated infections
(HAIs) and the incidence is increasing, with many strains now resistant to multiple antibiotic …

Background Due to limited therapeutic options and their association with high mortality and
morbidity, carbapenem-non-susceptible Acinetobacter spp.(CNA) are of significant public …

Identification and validation is the first phase of target-based antimicrobial development.
BfmR (RstA), a response regulator in a two-component signal transduction system (TCS) in …